Skip header and navigation

3 records – page 1 of 1.

Dilated cardiomyopathy (DCM) : Inherited Heart Disease (IHD) Clinic

https://libcat.nshealth.ca/en/permalink/chpams34671
Nova Scotia Health Authority. QEII. Inherited Heart Disease Clinic. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
0629
Available Online
View Pamphlet
In dilated cardiomyopathy (DCM), the heart muscle becomes weak. This makes it harder for the heart to pump blood out to the body. This causes the bottom chambers to dilate (stretch). A weak heart can also cause fluid to build up in parts of the body like the lungs (causing shortness of breath) and the ankles or belly (causing swelling). DCM may also affect the electrical activity of the heart and can cause fast, dangerous heart rhythms. The pamphlet gives the causes of DCM, symptoms, diagnostic…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Inherited Heart Disease Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
Cardiovascular disorders
Cardiomyopathy
Subjects (LCSH)
Heart--Hypertrophy
Myocardium--Diseases
Specialty
Cardiovascular system
Abstract
In dilated cardiomyopathy (DCM), the heart muscle becomes weak. This makes it harder for the heart to pump blood out to the body. This causes the bottom chambers to dilate (stretch). A weak heart can also cause fluid to build up in parts of the body like the lungs (causing shortness of breath) and the ankles or belly (causing swelling). DCM may also affect the electrical activity of the heart and can cause fast, dangerous heart rhythms. The pamphlet gives the causes of DCM, symptoms, diagnostic procedures and treatments (medications, a special pacemaker or internal defibrillator and rarely a heart transplant). Websites for further information are also noted.
Notes
Previous title: DCM: Dilated Cardiomyopathy
Responsibility
Prepared by: Inherited Heart Disease Clinic, QEII, Halifax
Pamphlet Number
0629
Less detail

Hypertrophic cardiomyopathy

https://libcat.nshealth.ca/en/permalink/provcat34079
Srihari S. Naidu, editor ; foreword by Bernard Gersh and historical context by Eugene Braunwald. --London: Springer , c2015.
Available Online
View e-Book
Location
Online
This book provides a comprehensive clinical review of Hypertrophic Cardiomyopathy (HCM), the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level, resulting in the development of abnormal and occasionally focal hypertrophy on a macroscopic level. Editor, Srihari S. Naidu, has brought together a world renowned group of experts to review various different topics but, with a practical focus that will enable readers to establish the evidence-…
Available Online
View e-Book
Other Authors
Naidu, Srihair S.
Responsibility
Srihari S. Naidu, editor ; foreword by Bernard Gersh and historical context by Eugene Braunwald
Place of Publication
London
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xvi, 321 pages)
ISBN
9781447149569 (electronic bk.)
9781447149552
Subjects (MeSH)
Cardiomyopathy, Hypertrophic
Subjects (LCSH)
Heart - Hypertrophy
Abstract
This book provides a comprehensive clinical review of Hypertrophic Cardiomyopathy (HCM), the most common genetic disorder of the heart characterized by dysfunctional contractility at the sarcomere level, resulting in the development of abnormal and occasionally focal hypertrophy on a macroscopic level. Editor, Srihari S. Naidu, has brought together a world renowned group of experts to review various different topics but, with a practical focus that will enable readers to establish the evidence-based best practice in any potential scenario. Treatment modalities including medications, pacemakers and defibrillators, and invasive septal reduction therapy (both surgical myectomy and alcohol septal ablation) will be discussed. Chapters on genetics, family screening, lifestyle concerns, and athletic screening have additionally been added given the ongoing controversies and differences of opinion on many of these issues. Each chapter within Hypertrophic Cardiomyopathy begins with key points of knowledge and ends with clinical pearls that have not previously been disseminated to the wider community. The practical approach of the entire book continues with dedicated chapters on creating a Center of Excellence, including how to facilitate the multi-disciplinary approach, and on case-based reviews and discussions allowing readers to further understand how to integrate the knowledge gained from each chapter into the comprehensive and longitudinal care of the individual patient and family. The last chapter takes the reader through the management of actual patients, showing over decades the nuances to diagnosis and management and the sometimes abrupt changes in the course of their diseases that necessitate correspondingly abrupt modifications in treatment.
Contents
Hypertrophic Cardiomyopathy: The Past, The Present, and The Future -- Natural History of Untreated Hypertrophic Cardiomyopathy -- Pathology and Pathophysiology -- Approach to Diagnosis: Echocardiography -- Cardiac MRI in Diagnosis and Management -- Genetics of HCM and Role of Genetic Testing -- Assessment of Heart Failure: Invasive and Non-invasive Methods -- Assessment of Syncope -- Pediatric Diagnosis and Management -- Sudden Cardiac Death Risk Assessment -- Youth and Athletic Screening: Rationale, Methods and Outcome -- Lifestyle Modification: Diet, Exercise, Sports and Other Issues -- Family Screening: Who, When and How -- Medical Therapy: From Beta-Blockers to Disopyramide -- Indications and Outcome of PPM and ICD Placement -- Management of Arrhythmia: Medications, Electrophysiology Studies and Ablation -- Indications for and Individualization of Septal Reduction Therapy -- Surgical Myectomy and Associated Procedures: Techniques and Outcomes -- Alcohol Septal Ablation: Technique and Outcome -- End-Stage Diastolic and Systolic Heart Failure: Evaluation and Timing of Heart Transplantation -- Approach to the Initial and Follow-Up Visits -- Evaluation and Management of Hypertrophic Cardiomyopathy Patients through Noncardiac Surgery and Pregnancy -- Constructing a Hypertrophic Cardiomyopathy Center of Excellence -- Longitudinal Case-Based Presentations in HCM.
Format
e-Book
Location
Online
Less detail

Hypertrophic cardiomyopathy (HCM) : Inherited Heart Disease (IHD) Clinic

https://libcat.nshealth.ca/en/permalink/chpams34669
Nova Scotia Health Authority. QEII. Inherited Heart Disease Clinic. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
0631
Available Online
View Pamphlet
In HCM, there is a thickening of the heart muscle, usually in the wall between the 2 lower chambers (the septum). When the muscle thickens, it gets stiff and makes it hard for the bottom chambers to relax and fill with blood before each heartbeat. Thickening can also make it harder for blood to leave the heart. This can lower the amount of blood the heart can pump out to the rest of the body. Thickening of the heart muscle can create scar tissue. This can make you more at risk of dangerous, fas…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Inherited Heart Disease Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([6] p.) : digital, PDF file
Subjects (MeSH)
Cardiovascular disorders
Cardiomyopathy
Subjects (LCSH)
Heart--Hypertrophy
Myocardium--Diseases
Specialty
Cardiovascular system
Abstract
In HCM, there is a thickening of the heart muscle, usually in the wall between the 2 lower chambers (the septum). When the muscle thickens, it gets stiff and makes it hard for the bottom chambers to relax and fill with blood before each heartbeat. Thickening can also make it harder for blood to leave the heart. This can lower the amount of blood the heart can pump out to the rest of the body. Thickening of the heart muscle can create scar tissue. This can make you more at risk of dangerous, fast heart rhythms. The pamphlet gives the most common cause (inherited) of HCM, symptoms, diagnostic procedures, and treatment (medications, a special pacemaker called an internal cardioverter defibrillator). Websites for further information are also noted.
Responsibility
Prepared by: Inherited Heart Disease Clinic, QEII, Halifax
Pamphlet Number
0631
Less detail